Assignee
SEELOS THERAPEUTICS INC
US·6 granted patents·9 pending applications·8 citations·filing 2014–2025
Top patents by PatentIndex Score
15 records- 0191US10869831B2Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehaloseSEELOS THERAPEUTICS INC·Filed 2019·Granted Dec 22, 2020·3 cites·14 claims
- 0285US10751353B2Compositions and methods for treating an aggregation disease or disorderSEELOS THERAPEUTICS INC·Filed 2019·Granted Aug 25, 2020·3 cites·16 claims
- 0383US12440457B2Methods of treating suicidalitySEELOS THERAPEUTICS INC·Filed 2023·Granted Oct 14, 2025·1 cites·26 claims
- 0483US12239733B2Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehaloseSEELOS THERAPEUTICS INC·Filed 2023·Granted Mar 4, 2025·0 cites·18 claims
- 0574US2026014072A1Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehaloseSEELOS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0673US10493023B2Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehaloseSEELOS THERAPEUTICS INC·Filed 2014·Granted Dec 3, 2019·1 cites·16 claims
- 0773US2022117883A1Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehaloseSEELOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0872US2025241936A1Compositions and methods for treating an aggregation disease or disorderSEELOS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0971US2021008089A1Compositions and methods for treating an aggregation disease or disorderSEELOS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1066US2022288096A1Compositions and methods for treating an aggregation disease or disorderSEELOS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1159US2026021126A1Trehalose formulations and uses thereofSEELOS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1256US12370204B2Trehalose formulations and uses thereofSEELOS THERAPEUTICS INC·Filed 2020·Granted Jul 29, 2025·0 cites·20 claims
- 1353US2023064327A1Reducing side effects of nmda antagonistsSEELOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1451US2024261236A1Methods of using nmda receptor antagonistsSEELOS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1548US2024025953A1Compositions and methods for inhibiting alpha-synuclein aggregationSEELOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SEELOS THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →